https://www.selleckchem.com/products/Eloxatin.html
Plasma-derived von Willebrand factor/factor VIII (pdVWF/FVIII; VONCENTO , CSL Behring) is a high-concentration, low-volume, high-purity concentrate, which contains a high level of high-molecular-weight multimers and a VWF/FVIII ratio of ~2.41. The SWIFT ("Studies with von Willebrand factor/Factor VIII" program is evaluating pdVWF/FVIII in patients with von Willebrand disease (VWD). The long-term efficacy and safety profile of pdVWF/FVIII was investigated in this multicenter, open-label, extension study. Pediatric, adolescent, and adul
Like
Comment
Share
